NEW YORK, Nov. 20, 2017 /PRNewswire/ -- • The global market for antiseptics and disinfectants reached $6.4 billion and $6.7 billion in 2015 and 2016, respectively. This market is estimated to reach $9.1 billion in 2022 from nearly $7.1 billion in 2017 at a compound
Read the full report: https://www.reportlinker.com/p05208425
• Quaternary ammonium compounds as a segment is expected to grow from nearly $1.4 billion in 2017 to $1.9 billion in 2022 at a CAGR of 6.4% from 2017 through 2022. • Oxidizing agents as a segment is expected to grow from $1.3 billion in 2017 to $1.8 billion in 2022 at a CAGR of 6.6% from 2017 through 2022. Chapter 1: Introduction Study Goals and Objectives Hygiene at home or in hospitals is important for a healthy and disease-free environment. Antiseptics and disinfectants play major roles in maintaining proper/good hygiene. People are becoming more and more aware of the importance of sanitization and cleanliness, and this is helping the antiseptics and disinfectants market.
BCC Research's goal in conducting this study is to provide an overview of the current and future characteristics of the global market for antiseptics and disinfectants. This report explores present and future strategies within the antiseptics and disinfectants market, which includes biguanides and amidines, phenol and derivatives, quaternary ammonium compounds, oxidizing agents, alcohols, aldehydes, iodine products, silver compounds, and other antiseptics and disinfectants such as 8 hydroxyquinoline, dequalinium, chlorquinaldol, and so forth. A detailed analysis of the industry structure for antiseptic and disinfectant products has been conducted. Revenues are broken down by region and sales figures are estimated for the five-year period from 2017 through 2022. Applications for antiseptic and disinfectant products are also discussed in the report. In addition, the report covers significant patents and their allotments in each relevant category.
Reasons for Doing This Study Antiseptics and disinfectants are essential means of cleaning and disinfecting skin, devices, hard surface areas, and so forth. In recent years, the growing threat of infections and associated morbidity and mortality has led more and more people to use antiseptics and disinfectants in order to prevent infections. The market for antiseptics and disinfectants is growing at a steady rate across all regions, with emerging markets growing at a slightly faster rate. R&D spending and upcoming technologies, along with increasing competition, are giving a new direction to the market. Advancements, new product launches, changing lifestyles, and awareness of the importance of cleanliness have influenced market growth and will continue to do so in the future. This study looks at almost all of the segments affected by these factors. Acquisition strategies and collaborations by companies are also covered in this report. The study also discusses the strength and weaknesses of each type of antiseptic and disinfectant in light of new technologies, growing competition, and changing customer needs.
Scope of Report Microbial infections represent one of the leading causes of death worldwide. Users of antiseptics and disinfectants are individual consumers as well as various groups and industries such as research institutions, food handlers, textile manufacturers, healthcare providers, and so forth. Antiseptics and disinfectants are a vital set of compounds for healthy living. This report focuses on the global market for antiseptic and disinfectant products and provides an updated review of their applications. The report deals with antiseptic and disinfectant products by covering the total market, which includes two main areas of applications: antiseptics and disinfectants for domestic use and antiseptics and disinfectants for institutional/ commercial use. This report details regulatory aspects; innovations and technological improvements, including patents and approvals; and latest trends, preferences and progress in the antiseptic and disinfection products market. The report analyzes the global antiseptics and disinfectants market by category, region and application. North America (U.S. and Canada), Europe (France, Germany, Italy, the U.K., Russia, Spain), and emerging markets (many Asian countries, South Korea, parts of Africa, Brazil, India, China) are considered in the regional market analysis. In addition, the study also covers the market projections, market leaders, and market shares in the worldwide market for antiseptic and disinfection products. Information Sources Many companies were surveyed to obtain data for this study. Included were manufacturers and end users of antiseptic and disinfectant products. Data was gathered from various industry sources. BCC Research spoke with officials within the industry and consulted newsletters, company literature, product literature, and a host of technical articles, journals, indexes, and abstracts. Exhaustive investigations of databases by key terminology were completed. In addition, data were compiled from current financial, trade, and government sources. Methodology Both primary and secondary research methodologies were used in preparing this study. BCC Research conducted a comprehensive literature search, which included technical newsletters and journals and many other sources. Data was collected through interviews and correspondence with manufacturers and users of antiseptic and disinfectant products. Statistical techniques were used for the projection of sales data for the global and regional antiseptic and disinfectant markets. The projections were based on past sales and upcoming trends in manufacturing, taking into account changes in the consumer market, regulatory decisions, and pricing. The details of antiseptics and disinfectants in the report are based on their present/prospective applications, expediency, and appropriateness of the products. Regional Breakdown
In this report, the regions considered for market analysis include, and only include: • North America. o U.S. o Canada. • Europe. o France. o Germany. o Italy. o U.K. o Russia. o Spain. • Emerging markets. o Many Asian countries. o China. o India. o South Korea. o Africa. o Brazil. Antiseptics and Disinfectants, by Type Biguanides and amidines Phenol and derivatives Quaternary ammonium compounds Oxidizing agents Alcohols Aldehydes Iodine products Silver compounds Other antiseptics and disinfectants Antiseptics and Disinfectants, by Application Antiseptics and disinfectants for domestic use Antiseptics and disinfectants for institutional/ commercial use Chapter 2: Summary and Highlights Microorganisms and infectious pathogens cause a variety of illnesses in animals and humans. Antiseptics and disinfectants are important tools for controlling and/or eliminating these infectious pathogens. Antiseptics in the form of hand washes, hand rinses, sanitizers, gels, soaps, wipes, and scrubs are used on skin, mucosa or cavities to destroy pathogens and/or inhibit their growth. Disinfectants in the form of solutions, powder, sprays, gels, and so forth are used for decontamination of surfaces, equipment, or other inanimate objects. Antiseptics and disinfectants are marketed directly to consumers and to various industries including healthcare, pharmaceutical, hospitality and hotel, food and beverages, textile, research, and so forth. Many antiseptics and disinfectants based on different antimicrobial chemistries (such as quaternary ammonium compounds, and phenol and derivatives), are registered with the Environmental Protection Agency (EPA), approved by the U.S. Food and Drug Administration (FDA), and currently available in the market. These antiseptics and disinfectants have diverse modes of action for killing or inhibiting the growth of microorganisms such as bacteria, viruses and fungi. In the 21st century, hygiene and sanitation are global development priorities. Various global welfare organizations such as the World Health Organization (WHO) as well as private companies are taking several initiatives to make people aware of the importance of hygiene and sanitation. With growing consumer awareness, stringent regulatory policies, and novel product launches, the role of antiseptics and disinfectants in preventing and controlling microbial infections and diseases is constantly growing in all application areas including domestic use as well as institutional and commercial use. Healthcare settings, the pharmaceutical industry, the hospitality and hotel industry, community centers, public places, and the food and beverages industry, among others, are some of the largest user segments of antiseptic and disinfectant products. In particular, the presence of pathogens in the healthcare environment is a critical safety concern that poses a life-threatening risk to patients. Thus, antiseptics and disinfectants are used in healthcare settings on a large scale to control and prevent crosscontamination.
In the last five years to seven years, there has been an increase in outbreaks of infectious diseases caused by pathogens such as Clostridium difficile, severe acute respiratory syndrome–associated coronavirus (SARS-CoV), Middle East respiratory syndrome–associated coronavirus (MERS-CoV), and others. Given the growing interconnectivity and ease of modern travel, the potential for these pathogens to transmit swiftly from one part of the world to the other, causing large-scale damage, is greater than ever. The situation highlights the need to follow stringent hygiene and sanitation practices in all walks of life to protect mankind from these deadly pathogens. The market for antiseptics and disinfectants is highly fragmented and made of several small and big companies. Some of the big players in the market are 3M Co.; ABC Compounding Inc.; Becton, Dickinson and Co.; BODE Chemie GmbH; Colgate-Palmolive Co.; Covidien Ltd.; Diversey Care Inc.; Dow Chemical Co.; Ecolab Inc.; GlaxoSmithKline PLC; Henkel AG & Co. KGaA; Johnson & Johnson; Kimberly-Clark; Medtronic PLC; Professional Disposables Inc.; Reckitt Benckiser Group PLC; Steris Corp.; The Clorox Co.; The Procter & Gamble Co.; and many others. Increasing awareness about the importance of hygiene and sanitation in preventing and controlling microbial infections, particularly in developing parts of the world, and increasing demand in the healthcare and food sectors are the major reasons for growth in the global antiseptics and disinfectants market during the examined period. Advances in antimicrobial technologies and their widening applications in different sectors including healthcare, personal care, home care, textiles, and so forth, as well as product launches, have also had a positive impact on the market during the studied period. As the table shows, the global antiseptics and disinfectants market is expected to reach $9.1 billion by 2022, growing at a CAGR of 5.2%. The previous report (CHM052C – Antiseptics and Disinfectants) forecasted the market to be around $7.9 billion, with a CAGR of 7% through 2020. The major slowdown occurred in the phenol and derivatives market. It was projected to grow at a CAGR of 7.6% in the previous report. Due to the effect of the U.S. Food and Drug Administration's September 2016 ban on phenol and many widely used phenol derivatives from over-the-counter (OTC) consumer antiseptic products, this report projects the phenol and derivatives market to grow at a much lesser rate, with a CAGR of 1.5% through 2022. Iodine products also witnessed a significant slowdown (with a previously forecasted CAGR of 6.0% versus this report's CAGR of 3.5%), due to the FDA's ban on certain iodophors (iodine-containing ingredients) from over-the-counter (OTC) consumer antiseptic products. However, this report projects the market for silver-based antiseptics and disinfectants to grow at a much higher CAGR of REDACTED compared with the previous report's projection of REDACTED. Silver-basedantiseptics and disinfectants still constitute a very small share (REDACTED) in the global antiseptics anddisinfectants market, but their market is growing the fastest given their expanding applications indifferent fields including textiles, food, medical-device disinfection, personal-care products, and others. Several innovative silver-based antimicrobial technologies such as PURE Bioscience Inc.'s SilverDihydrogen Citrate (SDC) antimicrobial technology and Sciessent LLC's Agion Antimicrobial technologyare available in the market and are helping the market to grow. The oxidizing agent–based antisepticsand disinfectants are also projected to grow at a higher CAGR (6.6%) than the previous report predicted (REDACTED), due to the approval of several oxidizing agent–based disinfectants by the EPA during theexamined period; these are discussed in the Patent Review/New Developments chapter of this report. Changing regulatory policies and the increasing rate of antimicrobial resistance are a few of the challenges that the antiseptics and disinfectants market has been facing more aggressively in the last three years to five years. In light of emerging and reemerging infectious diseases and growing instances of large outbreaks of infectious diseases caused by pathogens such as Clostridium difficile, SARSassociated coronavirus (SARS-CoV), Middle East respiratory syndrome–associated coronavirus (MERSCoV), and others, the growth in the antiseptics and disinfectants market is expected to remain steady through 2022.
Read the full report: https://www.reportlinker.com/p05208425 About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: firstname.lastname@example.org US: (339)-368-6001 Intl: +1 339-368-6001
View original content:http://www.prnewswire.com/news-releases/the-global-market-for-antiseptics-and-disinfectants-reached-64-billion-and-67-billion-in-2015-and-2016-300559705.html
Subscribe to our Free Newsletters!
Sleep paralysis is a condition where one feels unable to move (paralysis) or speak either when ...
Summers days are long, hot and sweaty, and can leave you feeling de-hydrated and tired. Read on to ...
Fosnetupitant and Palonosetron (a fixed antiemetic combination) injection was approved by FDA in ...View All